A kind of oral sustained-release antihypertensive composition
A technology of composition and sustained release agent, which is applied in the field of antihypertensive compound drugs, and can solve the problem of high treatment cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Prescription of bevanolol sustained-release tablets (content per tablet)
[0039] Bevanolol 100.0mg
[0040] Hydroxypropyl methylcellulose 105.0mg
[0041] Starch 100.0mg
[0042] Povidone 18.0mg
[0043] Stearic acid 7.0mg
[0044] Micro Silica Gel 2.0g
[0045] 70% ethanol appropriate amount
[0046] Total weight 332mg
[0047] Enalapril immediate-release tablet prescription (content per tablet)
[0048] Enalapril 2.5mg
[0049] Cross-linked polyvinylpyrrolidone 30mg
[0050] Microcrystalline Cellulose 55mg
[0051] Povidone 10mg
[0052] Micro silica gel 2.5mg
[0053] 70% ethanol appropriate amount
[0054] Total weight 100mg
[0055] Take bevanolol and enalapril and pass through a 100-mesh sieve respectively, starch, microcrystalline cellulose, hydroxypropyl methylcellulose, povidone and stearic acid respectively pass through a 100-mesh sieve, set aside, prepare 1000 samples Prescription amount, take the prescription amount of bevanolol, hydroxypropyl...
Embodiment 2
[0057] The operation of Example 1 was repeated except that the amounts of the components were changed to obtain compressed bilayer tablets.
[0058] Prescription of bevanolol sustained-release tablets (content per tablet)
[0059] Bevanolol hydrochloride 50.0mg, ethyl cellulose 80.0mg, lactose 150.0mg, povidone 18.0mg, magnesium stearate 2.0g, acetone amount, total weight 300.0mg
[0060] Enalapril immediate-release tablets
[0061] Enalapril maleate 5.0 mg, low-substituted hydroxypropyl cellulose 40.0 mg, lactose 40.0 mg, povidone 8 mg, magnesium stearate 2.0 mg, 70% ethanol in appropriate amount, total weight 100.0 mg.
Embodiment 3
[0063] The operation of Example 1 was repeated except that the amounts of the components were changed to obtain compressed bilayer tablets.
[0064] Prescription of bevanolol sustained-release tablets (content per tablet)
[0065] Bevanolol Hydrochloride 200.0mg, Xanthan Gum 100.0mg, Stearic Acid 10.0mg, Magnesium Stearate 2.0g, 30% ethanol in proper amount, total weight 312.0mg
[0066] Enalapril immediate-release tablets
[0067] Enalapril maleate 2.5mg, polyvinylpyrrolidone 50.0mg, lactose 40.0mg, povidone 6.5mg, magnesium stearate 1.0mg, 70% ethanol amount, total weight 100.0mg.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com